Alpha Sophia is set to make waves at the LSI USA 2024 Emerging MedTech Summit in Dana Point, California, from March 18-22. Led by CEO Paul-Lukas Hoffschmidt, Alpha Sophia will unveil a major product update during the event, promising significant enhancements to its platform and model.
Hoffschmidt will spearhead a thought leadership session on March 21 alongside industry experts Brad Patt (Tetrous), Robert Hamilton (Neurasignal), and James Peacock (Nocira). This session will mark the formal announcement of game-changing improvements to the Alpha Sophia platform, tailored to meet the needs of medtech sales leaders.
The updates showcased at the LSI summit are poised to redefine the landscape of go-to-market tactics for the Medtech industry, offering innovative solutions that address the dynamic challenges faced by professionals in this field. Alpha Sophia remains committed to driving meaningful change and empowering sales professionals with cutting-edge tools and strategies.
Baseimmune, a biotech company that uses proprietary, deep learning AI to predict future pathogen mutations to generate novel vaccines, has raised $11.3 million in a Series A funding round led by new investors MSD Global Health Innovation Fund and IQ Capital. Existing investors also took part in the round, including Hoxton Ventures, Creator Fund, Beast Ventures and Maki.vc.
The funding will be used to accelerate development of Baseimmune’s three vaccine candidates currently in preclinical development for African swine fever, coronavirus, and malaria. The funding will also be used to advance its technology, add staff, increase the number of programs in development and accelerate new vaccine programs.
To read more, click here.
Abridge, which focuses on generative AI for clinical documentation, has raised $150 million in a Series C funding round. Abridge has also embarked on a new enterprise agreement with the Yale New Haven Health System, according to a press release.
Lightspeed Venture Partners led the round and will also join the board. Other new and existing investors include co-lead Redpoint Ventures, with support from IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and CVS Health Ventures.
To read more, click here.
Carewell, an online retailer focused on serving family caregivers with tools and resources to care for their loved ones, has raised a $24.7 million Series B round. The goal is to further accelerate streamlining access to home health products, according to a press release. The principals of MBF Healthcare led the round, with participation from existing investors Sageview Capital and Headline, among others. Additionally, the company has made several senior level hires amidst plans to relocate their headquarters to Miami.
Additional investors in this round of funding include Primetime Partners, Nextview, Florida Opportunity Fund, and Anchor.
To read more, click here.
Redi Health has closed $14 million in a Series B funding round. The funding round was led by Blue Heron Capital. North Coast Ventures and existing investors Refinery Ventures, Mutual Capital Partners, Rev1 Ventures and M25 also took part in the round.
Redi Health combines health management technology to help people manage chronic conditions with digital pharma services. It will use the fresh capital to develop and launch new products, expand its network and accelerate overall growth, according to a press release.
To read more, click here.
Photo: champpixs, Getty Images
